Position in GRFS
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$818
+$706 QoQ
Shares Held
102
+750.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MV CAPITAL MANAGEMENT, INC. holds $82,370,025 across 15 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
271,250 | $68,257,350 | |
| 2 | JNJ |
Johnson & Johnson
|
14,678 | $3,727,771 | |
| 3 | AMGN |
Amgen Inc
|
8,630 | $3,125,095 | |
| 4 | LLY |
ELI LILLY & Co
|
2,477 | $2,970,988 | |
| 5 | MRK |
Merck & Co., Inc.
|
22,792 | $2,928,772 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,582 | $957,909 | |
| 7 | PFE |
Pfizer Inc
|
10,065 | $242,365 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,153 | $66,435 |
All Filings in GRFS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $818 | 102 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $112 | 12 | Shares | Sole | 2026-02-23 | |
| No filing history on record for this holder in this stock. | ||||||